Introduction
The aryl hydrocarbon receptor (AhR), a ligand-dependent transcription factor, mediates a variety of biological processes [[1] ]. AhR is a classic receptor for environmental toxicants/carcinogens such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and 3-methylcholanthrene (3MC). Upon binding to these ligands, AhR could adversely affect embryonic and fetal growth as well as male and female reproduction [[1], [2] ]. For instance, prenatal exposure to TCDD may cause fetotoxicity, delayed puberty, decreased sperm count, and reduced fertility [[2] ]. Interestingly, AhR knockout in mice can also lead to similar adverse phenotypes in the reproductive system (e.g., impaired implantation and pregnancy) [[3] - [6] ]. Thus, these data clearly indicate the physiological roles of AhR in implantation and pregnancy.
Preeclampsia is a life threatening complication of pregnancy, accounting for almost 10-15% of pregnancy-associated deaths and one of the major causes of iatrogenic prematurity among newborns [ [7] ]. The pathogenesis of preeclampsia is thought to act at three levels, defective placentation, placental ischemia, and endothelial cell dysfunction.
Protein expression of AhR has been identified in the placentas of many mammalian species including mouse and rabbit [[8] , [9] ]. Human placentas also contained high density of specific binding sites for TCDD as compared with rat and mouse livers, implying high AhR expression in human placentas [[10] ]. This was confirmed by the observation that human placentas had highest levels of AhR mRNA among many human organs including lung, liver, heart, brain, and kidney [ [11] ]. Recently, we have also reported that AhR protein is highly expressed in term human placentas, although no difference in AhR protein levels was detected between normal (N) and severe preeclamptic (sPE) placentas [[12] ]. However, the information on AhR protein expression in mild preeclamptic (mPE) and first trimester placentas was still lacking. Herein, we examined the AhR protein expression in term human placentas from women with N and mPE pregnancies as well as in first trimester placentas using immunohistochemistry and Western blotting.
Materials and methods

Tissue collection
Term placentas were obtained immediately after cesarean section delivery from women with N (n = 14) and mPE (n = 10) pregnancies as described [[12] , [13] ]. The first trimester placentas (n = 12) were obtained from women with induced abortion at gestation time of 6-8 weeks. Collection of placentas was approved by the Ethics Committee of Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine. Written informed consent to participate in the study was obtained from each patient. Preeclampsia was defined according to the guideline of USA National Institutes of Health publication No. 00-3029 [ [14] ]. The mPE was defined as onset of hypertension during late pregnancy with systolic and diastolic blood pressure more than 140 / 90 mmHg on at least two occasions and urinary protein more than 0.3g / 24h. All of the study subjects didn't have any medication during gestation. They were free of major diseases and substance abuse. Smokers were excluded. Patients' ages were similar between N and mPE pregnancies. There was no significant difference in gestation ages and fetal weights between N and mPE pregnancies (see table 1). Placental tissues under the chorionic and basal plates were dissected (~10 g each), snap-frozen and quickly stored in liquid nitrogen for Western blotting. Additional placental tissues from first trimester (n = 5) and term placentas (n = 5), and mPE placentas (n = 5) were fixed overnight at 4°C using 4% paraformaldehyde in 10 mM PBS and embedded them in paraffin for immunohistochemistry. Table 1 . The characteristics of women from normal and mPE pregnancies.
Immunohistochemistry
Immunolocalization of AhR in placental tissues was visualized by indirect observation via the avidin:biotinylated-peroxidase complex method (Vector Laboratories, Burlingame, CA) as described [[12] , [13] ]. Tissue sections (5 μm thick) were deparaffinized and dehydrated, followed by incubating the sections in a 10 mM citrate buffer solution (pH 6.0) in a microwave for 10 min for antigen retrieval. Then the tissue sections were immersed in 3% H 2 O 2 in methanol for 10 min in order to quench endogenous peroxidase activity. After blocking the non-specific binding sites with 1% horse serum albumin, the sections were incubated with a rabbit AhR antibody (1:500; BIOMOL International, Plymouth Meeting, PA) for 1 h and a biotinylated mouse anti-rabbit antibody (ABC kit; Vector Laboratories) for 30 min. The specific immunoreactivity was visualized by 3-amino-9-ethylcarbazole (AEC, Vector Laboratories). The tissue sections were lightly counter-stained with Harris Modified Hematoxylin (Fisher Scientific, Pittsburgh, PA). Additional adjacent tissue sections as negative controls were incubated with the same dilution of preimmune rabbit IgG as the primary antibody.
Western blotting
Western blotting was carried out as described [ [12] , [13] ]. Placental tissues were pulverized in liquid nitrogen using a mortar and pestle, followed by prepared in RIPA lysis buffer (50 mM HEPES, 0.1 M NaCl, 10 mM EDTA, 4 mM sodium pyrophosphate, 10 mM sodium fluoride, 2 mM sodium orthovanadate [pH 7.5]; 1 mM phenyl methyl sulfonyl fluoride [PMSF], 1% Triton X-100, 5 µg/ml leupeptin, 5 µg/ml aprotinin), and further lyzsed by sonication. After centrifugation, the supernatant was saved and protein concentrations in supernatants were determined by BCA kit.
The protein samples (40 g) were subjected to electrophoresis on 10% SDS-PAGE gels, followed by electrically transferring to polyvinylidene difluoride membranes. The membranes were incubated with the AhR antibody (1:2000; BIOMOL) and then reprobed with a GAPDH (1:5000; KANGCHEN, Shanghai, China) antibody as a loading control. Membranes were reacted with ECL reagents (Amersham Biosciences, Piscataway, NJ). Protein bands on the membranes were visualized by exposuring them to chemiluminescence films. The immunoreactive signals were analyzed by densitometry. The optical density (OD) value was measured by the Image-J imaging analysis software (US National Institutes of Health; Bethesda, MD). www.intechopen.com
Statistics procedures
Data for the AhR protein levels were analyzed using the Student's t-test (SigmaStat; Jandel Co., San Rafael, CA); *p ≤ 0.05 were considered to be statistically significant.
Results
AhR protein localization and expression in N and mPE placentas
Positive reddish staining for AhR was observed primarily in syncytiotrophoblasts in N and mPE placentas. There was also moderate staining in endothelial cells from large blood vessels ( Fig. 1A and 1 B) as described ( [12] ). The protein levels of AhR in N and mPE placentas were further determined by Western blotting (Fig. 2) . The AhR band was detected at ~95 kDa ( Fig. 2A) as previously reported in many species including human [ [12] , [15] ]. The AhR protein levels in mPE placentas were approximately 5.6 fold higher (p ≤ 0.05) than those in N placentas (Fig. 2B ).
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Protein expression of AhR in first trimester placentas
Similar to term plancentas, AhR was also mainly immunolocalized in syncytiotrophoblasts in first trimester placental villi (Fig. 3A) . However, in contrast to term placentas, moderate positive AhR staining was observed in capillaries within first trimester placental villi (Fig.  3B) , suggesting the possible roles of AhR in mediating placental endothelial functions including angiogenesis during human early pregnancy. Western blot analysis indicated that overall AhR protein levels in term placentas were ~ 2.2 fold higher (p ≤ 0.05) than those in first trimester placentas (Fig. 4) . 
Disscusion
In the current study, we have described the expression and localization of AhR protein in human term placentas from N and mPE preeclamptic pregnancies as well as in human first trimester placentas using immunohistochemistry and Western blot analyses. It is the first, as far as we know, to report that higher AhR protein levels were associated with mPE, while much higher AhR protein levels were expressed in term placentas as compared to first trimester placentas. Another major finding of the current study was that intense AhR staining was detected primarily in syncytiotrophoblasts in both first trimester and term placentas. Interestingly, moderate AhR expression was observed in capillary endothelial www.intechopen.com cells within villi in the first trimester, but not term placentas (the current study and [12] ). These findings suggest that AhR might play a critical role in mediating syncytiotrophoblast function, particularly in mPE and term placentas. The distinct distribution patterns of AhR protein in different placental vasculatures (capillaries vs. large blood vessels) during early and late pregnancies also imply that AhR might differentially mediate placental endothelial functions. For example, AhR may actively mediate placental angiogenesis at early pregnancy and placental vasodilatation during late pregnancy.
The expression of AhR mRNA and protein has been reported in the placenta of many mammalians including mouse and rabbit [[8] , [9] ]. We have also reported the AhR protein expression in the term human placenta from N and sPE pregnancies using Western blot www.intechopen.com analysis [ [12] ]. The current study further showed the AhR protein expression in mPE and early pregnant placentas. Interestingly, the higher AhR protein levels were associated with mPE, while our previous work detected similar levels of AhR protein in normal term and sPE placentas [[12] ]. Although mechanisms underlying such differential AhR protein expression between mPE and sPE placentas remain to be elucidated, it is possible that such differences might attribute to the shorter gestation ages in sPE than mPE pregnancies since women with sPE were much more likely to suffer premature delivery. This is also in line with our present observation that placental AhR protein levels were much lower in early pregnancy than those in term pregnancy. These data also support the notion that the pathogenesis of mPE and sPE may not be completely the same as proposed previously [[15] ]. Moreover, the higher protein levels of AhR could be potentially used as a marker for predicting mPE when in conjunction with other clinical diagnoses.
Our current observations that AhR protein was mainly present in the cytoplasm and nuclei of syncytiotrophoblasts, but not in cytotrophoblast cells in both first trimester and full term placentas were in agreement with recent findings by Stejskalova et al [ [16] ], suggesting that AhR might predominantly act on syncytiotrophoblasts during human pregnancy. The exact roles of AhR in syncytiotrophoblasts are currently unclear. However, given that syncytiotrophoblasts are terminally differentiated cells and are also responsible for producing many types of steroid and peptide hormones. It is possible that AhR might dynamically mediate syncytiotrophoblast differentiation and placental hormonal synthesis, particularly during late pregnancy, to support pregnancy and embryo/fetal development in uteri as AhR null female mice have difficulties to do so [ [6] , [7] ]. In addition, higher AhR protein levels in term placentas than early pregnant placentas also suggest that the former might be more sensitive to AhR ligands' stimulation regardless if these ligands are derived from exogenous or endogenous sources [ [17] , [18] ].
In conclusion, together with the recent findings of endogenous AhR ligands produced by human and animals [ [17] , [18] ], the current data strongly support the notion that AhR plays important physiological roles in mediating normal differentiation and development of cytotrophoblast as well as placental endothelial cells to maintain successful pregnancy.
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